Oxford is emerging as a consistent producer of high-growth companies in Europe, challenging the dominance of London, Paris and Berlin. The university city's startups raised £429m (€509m) in 2025 across 34 deals, marking a modest increase from the £417m raised in 2024. This growth trajectory positions Oxford as an increasingly attractive hub for investors seeking promising opportunities beyond traditional European tech centers.

Drug discovery and biotech sectors are leading Oxford's funding surge. Companies like Blue Earth Therapeutics, which secured £56m in Series A funding, and Enara Bio with £24m in Series B, exemplify this trend. The deeptech sector also shows rapid expansion, with AI chip developer Fractile raising $22m (£16.7m) in early 2025 from Nato Innovation Fund, Kindred and Oxford Science Enterprises.

The Oxford Saïd Entrepreneurship Centre plays a pivotal role in this ecosystem development. Since 2017, the center has attracted approximately 14.5k attendees through its programs, training and events, including the flagship Oxford Saïd Entrepreneurship Forum. With 2,900 participants between 2024-2025, the center continues to foster entrepreneurship by providing critical funding, mentoring and education to aspiring founders like Jack Fertility's co-founders who credit the center for their startup journey.